Cargando…

Comprehensive profiling of neutralizing polyclonal sera targeting coxsackievirus B3

Despite their fundamental role in resolving viral infections, our understanding of how polyclonal neutralizing antibody responses target non-enveloped viruses remains limited. To define these responses, we obtained the full antigenic profile of multiple human and mouse polyclonal sera targeting the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Álvarez-Rodríguez, Beatriz, Buceta, Javier, Geller, Ron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570382/ https://www.ncbi.nlm.nih.gov/pubmed/37828013 http://dx.doi.org/10.1038/s41467-023-42144-2

Ejemplares similares

High-resolution mapping of the neutralizing and binding specificities of polyclonal sera post-HIV Env trimer vaccination
por: Dingens, Adam S, et al.
Publicado: (2021)

A rapid and quantitative assay for measuring neutralizing antibodies of Coxsackievirus B3
por: Chen, Pan, et al.
Publicado: (2016)

Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice
por: Xue, Yimin, et al.
Publicado: (2021)

From Polyclonal Sera to Recombinant Antibodies: A Review of Immunological Detection of Gluten in Foodstuff
por: Garcia-Calvo, Eduardo, et al.
Publicado: (2020)

Coxsackievirus B3 targets TFEB to disrupt lysosomal function
por: Mohamud, Yasir, et al.
Publicado: (2021)

Molecular mechanism of antibody neutralization of coxsackievirus A16
por: Zhang, Chao, et al.
Publicado: (2022)

In-vitro Detection of Phytopathogenic Fungal Cell Wall by Polyclonal Sera Raised Against Trimethyl Chitosan Nanoparticles
por: Joshi, Hemant, et al.
Publicado: (2019)

Metabolic reprogramming as a novel therapeutic target for Coxsackievirus B3
por: Kuk, Myeong Uk, et al.
Publicado: (2022)

Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays
por: Valdivia, Arantxa, et al.
Publicado: (2021)

In Vitro Characterization of Neutralizing Hen Antibodies to Coxsackievirus A16
por: Mwale, Pharaoh Fellow, et al.
Publicado: (2021)

Design of 4-Substituted Sulfonamidobenzoic Acid Derivatives Targeting Coxsackievirus B3
por: Shetnev, Anton A., et al.
Publicado: (2022)

Development of a pseudovirus based assay for measuring neutralizing antibodies against coxsackievirus B5
por: Chen, Pan, et al.
Publicado: (2017)

Affinity and catalytic heterogeneity of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with multiple sclerosis
por: Legostaeva, Galina A, et al.
Publicado: (2010)

Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal antibodies
por: Plagemann, P. G. W., et al.
Publicado: (1992)

Ubiquitination Is Required for Effective Replication of Coxsackievirus B3
por: Si, Xiaoning, et al.
Publicado: (2008)

Inhibition of coxsackievirus B3 by RNA interference (RNAi)
por: Kurreck, J, et al.
Publicado: (2006)

Coxsackievirus B3—Its Potential as an Oncolytic Virus
por: Geisler, Anja, et al.
Publicado: (2021)

THE NEUTRALIZATION OF ANTIPNEUMOCOCCUS IMMUNE BODIES BY INFECTED EXUDATES AND SERA
por: Cole, Rufus
Publicado: (1917)

VIRUS NEUTRALIZATION EXPERIMENTS WITH ROSENOW'S AND PETTIT'S ANTIPOLIOMYELITIC SERA
por: Stewart, Fred W., et al.
Publicado: (1928)

Immunohistochemical detection of enteroviruses in pancreatic tissues of patients with type 1 diabetes using a polyclonal antibody against 2A protease of Coxsackievirus
por: Jimbo, Erika, et al.
Publicado: (2021)

Analysis of Epitopes on Dengue Virus Envelope Protein Recognized by Monoclonal Antibodies and Polyclonal Human Sera by a High Throughput Assay
por: Lin, Hong-En, et al.
Publicado: (2012)

Antiviral Effects of Menthol on Coxsackievirus B
por: Taylor, David J.R., et al.
Publicado: (2020)

Coxsackievirus A16-like particles elicit neutralizing antibody responses in mice
por: Liu, Qingwei, et al.
Publicado: (2011)

Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody
por: Xu, Longfa, et al.
Publicado: (2017)

Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains
por: Huo, Yaqian, et al.
Publicado: (2021)

Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma
por: Mishra, Nitesh, et al.
Publicado: (2021)

Coxsackievirus B3, Shandong Province, China, 1990–2010
por: Tao, Zexin, et al.
Publicado: (2012)

Coxsackievirus B3 infection reduces female mouse fertility
por: Shim, Hye Min, et al.
Publicado: (2015)

Appendectomy Mitigates Coxsackievirus B3−Induced Viral Myocarditis
por: Niu, Chengrui, et al.
Publicado: (2023)

HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes
por: Ditse, Zanele, et al.
Publicado: (2018)

Examination of the Efficacy and Cross-Reactivity of a Novel Polyclonal Antibody Targeting the Disintegrin Domain in SVMPs to Neutralize Snake Venom
por: Szteiter, Shelby S., et al.
Publicado: (2021)

Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting
por: Doria-Rose, Nicole A., et al.
Publicado: (2017)

Superinfection Drives HIV Neutralizing Antibody Responses from Several B Cell Lineages that Contribute to a Polyclonal Repertoire
por: Williams, Katherine L., et al.
Publicado: (2018)

Polyclonal B‐cell lymphocytosis in English bulldogs
por: Rout, Emily D., et al.
Publicado: (2020)

Inhibition of coxsackievirus infection in cardiomyocytes by small dsRNA targeting its cognate coxsackievirus adenovirus receptor
por: Sharma, Mirnalini, et al.
Publicado: (2017)

Comprehensive profiling and characterization of cellular microRNAs in response to coxsackievirus A10 infection in bronchial epithelial cells
por: Hu, Yajie, et al.
Publicado: (2022)

Development of a Coxsackievirus A16 neutralization assay based on pseudoviruses for measurement of neutralizing antibody titer in human serum
por: Jin, Jun, et al.
Publicado: (2013)

Benserazide, the first allosteric inhibitor of Coxsackievirus B3 3C protease()
por: Kim, Bo-Kyoung, et al.
Publicado: (2015)

Transmission and Demographic Dynamics of Coxsackievirus B1
por: Chu, Pei-Yu, et al.
Publicado: (2015)

Vaccines against Group B Coxsackieviruses and Their Importance
por: Mone, Kiruthiga, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h9c5p0qts5ovlhgskaq3vnfedl